| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | DNA-dependent protein kinase activity | 1.30e-04 | 3 | 132 | 2 | GO:0004677 | |
| GeneOntologyMolecularFunction | histone H2AXS139 kinase activity | 1.30e-04 | 3 | 132 | 2 | GO:0035979 | |
| Domain | TMEM183 | 4.88e-05 | 2 | 131 | 2 | IPR026509 | |
| Domain | DUF2075 | 1.46e-04 | 3 | 131 | 2 | PF09848 | |
| Domain | TACC | 1.46e-04 | 3 | 131 | 2 | PF05010 | |
| Domain | DUF2075 | 1.46e-04 | 3 | 131 | 2 | IPR018647 | |
| Domain | TACC | 1.46e-04 | 3 | 131 | 2 | IPR007707 | |
| Domain | G_crystallin-rel | 2.55e-04 | 18 | 131 | 3 | IPR011024 | |
| Domain | FATC | 4.82e-04 | 5 | 131 | 2 | PF02260 | |
| Domain | ARM-type_fold | 6.53e-04 | 339 | 131 | 9 | IPR016024 | |
| Domain | FAT | 7.19e-04 | 6 | 131 | 2 | PS51189 | |
| Domain | FATC | 7.19e-04 | 6 | 131 | 2 | PS51190 | |
| Domain | FAT | 7.19e-04 | 6 | 131 | 2 | PF02259 | |
| Domain | PIK-rel_kinase_FAT | 7.19e-04 | 6 | 131 | 2 | IPR003151 | |
| Domain | FATC_dom | 7.19e-04 | 6 | 131 | 2 | IPR003152 | |
| Domain | PIK_FAT | 7.19e-04 | 6 | 131 | 2 | IPR014009 | |
| Domain | FATC | 7.19e-04 | 6 | 131 | 2 | SM01343 | |
| Domain | AlbA_2 | 1.00e-03 | 7 | 131 | 2 | PF04326 | |
| Domain | Schlafen | 1.00e-03 | 7 | 131 | 2 | IPR029684 | |
| Domain | Schlafen_AAA_dom | 1.00e-03 | 7 | 131 | 2 | IPR007421 | |
| Domain | DUF1220 | 1.70e-03 | 9 | 131 | 2 | SM01148 | |
| Domain | MKP | 2.12e-03 | 10 | 131 | 2 | IPR008343 | |
| Domain | DUF1220 | 2.58e-03 | 11 | 131 | 2 | PF06758 | |
| Domain | NBPF_dom | 2.58e-03 | 11 | 131 | 2 | IPR010630 | |
| Domain | NBPF | 2.58e-03 | 11 | 131 | 2 | PS51316 | |
| Domain | 6-blade_b-propeller_TolB-like | 4.11e-03 | 46 | 131 | 3 | IPR011042 | |
| Domain | Beta/gamma_crystallin | 4.83e-03 | 15 | 131 | 2 | IPR001064 | |
| Domain | PI3/4_kinase_CS | 4.83e-03 | 15 | 131 | 2 | IPR018936 | |
| Domain | CRYSTALLIN_BETA_GAMMA | 4.83e-03 | 15 | 131 | 2 | PS50915 | |
| Domain | Crystall | 4.83e-03 | 15 | 131 | 2 | PF00030 | |
| Domain | XTALbg | 4.83e-03 | 15 | 131 | 2 | SM00247 | |
| Domain | LRRNT | 5.02e-03 | 98 | 131 | 4 | IPR000372 | |
| Domain | LRRNT | 5.02e-03 | 98 | 131 | 4 | SM00013 | |
| Domain | - | 5.49e-03 | 16 | 131 | 2 | 1.10.1070.11 | |
| Domain | PI3Kc | 5.49e-03 | 16 | 131 | 2 | SM00146 | |
| Domain | LRRNT | 6.12e-03 | 53 | 131 | 3 | PF01462 | |
| Domain | PI3_PI4_kinase | 6.94e-03 | 18 | 131 | 2 | PF00454 | |
| Domain | PI3_4_KINASE_1 | 6.94e-03 | 18 | 131 | 2 | PS00915 | |
| Domain | PI3_4_KINASE_2 | 6.94e-03 | 18 | 131 | 2 | PS00916 | |
| Domain | PI3/4_kinase_cat_dom | 6.94e-03 | 18 | 131 | 2 | IPR000403 | |
| Domain | PI3_4_KINASE_3 | 6.94e-03 | 18 | 131 | 2 | PS50290 | |
| Pubmed | USP34 BIRC6 WDR26 FASN MRTFB ZNF608 WDCP ZBTB21 CRYBG3 TACC3 KIF11 | 7.82e-07 | 418 | 135 | 11 | 34709266 | |
| Pubmed | 3.21e-06 | 103 | 135 | 6 | 10574462 | ||
| Pubmed | Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism. | HEXA SIVA1 NBPF6 FCHO1 SDR39U1 ZGPAT RIF1 PKD1 GTPBP3 SPOCD1 RUBCN ABCC10 KIF11 DNMT3B MGRN1 | 3.34e-06 | 925 | 135 | 15 | 28986522 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | HEXA USP34 MEX3D HECTD4 LAMA5 BIRC6 LYST ABCA7 ZGPAT FASN PER2 DUSP16 PKD1 AKAP13 PRKDC ABCC10 | 6.48e-06 | 1105 | 135 | 16 | 35748872 |
| Pubmed | USP34 ISLR2 HECTD4 AAK1 LAMA5 ZNF608 TECPR2 ZBTB21 MED12L CARNS1 MGRN1 | 7.46e-06 | 529 | 135 | 11 | 14621295 | |
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | 1.31e-05 | 363 | 135 | 9 | 14691545 | |
| Pubmed | Synthetic lethality between mutation in Atm and DNA-PK(cs) during murine embryogenesis. | 1.50e-05 | 2 | 135 | 2 | 11231155 | |
| Pubmed | An immunocompromised murine model of chronic Bartonella infection. | 1.50e-05 | 2 | 135 | 2 | 20395436 | |
| Pubmed | Recruitment of ATM protein to double strand DNA irradiated with ionizing radiation. | 1.50e-05 | 2 | 135 | 2 | 10464290 | |
| Pubmed | Regulation of the DNA Damage Response by DNA-PKcs Inhibitory Phosphorylation of ATM. | 1.50e-05 | 2 | 135 | 2 | 27939942 | |
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 21487018 | ||
| Pubmed | The mouse mutation severe combined immune deficiency (scid) is on chromosome 16. | 1.50e-05 | 2 | 135 | 2 | 2908877 | |
| Pubmed | Activation of DNA Damage Response Pathways during Lytic Replication of KSHV. | 1.50e-05 | 2 | 135 | 2 | 26057167 | |
| Pubmed | Nonspecific immune responses and mechanisms of resistance to Eimeria papillata infections in mice. | 1.50e-05 | 2 | 135 | 2 | 9234770 | |
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 15781192 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 17392156 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 8140728 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 11847113 | ||
| Pubmed | Spontaneous and experimental infections in scid and scid/beige mice. | 1.50e-05 | 2 | 135 | 2 | 8320959 | |
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 19071136 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 12065055 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 17189255 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 19249873 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 22972376 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 8391609 | ||
| Pubmed | Murine granulated metrial gland cell population in beige (bg/bg) and SCID (scid/scid) genotypes. | 1.50e-05 | 2 | 135 | 2 | 8075241 | |
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 26774662 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 9175014 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 33802342 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 1639480 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 36727301 | ||
| Pubmed | Translocation of bacteria from the gastrointestinal tract in immunodeficient mice. | 1.50e-05 | 2 | 135 | 2 | 8709573 | |
| Pubmed | Role of gamma delta T cells in the inflammatory response of experimental colitis mice. | 1.50e-05 | 2 | 135 | 2 | 14607957 | |
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 8962121 | ||
| Pubmed | Loss of allostery and coenzyme B12 delivery by a pathogenic mutation in adenosyltransferase. | 1.50e-05 | 2 | 135 | 2 | 21604717 | |
| Pubmed | Origination and evolution of a human-specific transmembrane protein gene, c1orf37-dup. | 1.50e-05 | 2 | 135 | 2 | 16644869 | |
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 23094018 | ||
| Pubmed | Ubiquitin-specific protease 34 in macrophages limits CD8 T cell-mediated onset of vitiligo in mice. | 1.50e-05 | 2 | 135 | 2 | 37043976 | |
| Pubmed | Branhamella catarrhalis pathogenesis in SCID and SCID/beige mice. Brief report. | 1.50e-05 | 2 | 135 | 2 | 8267959 | |
| Pubmed | The gene for autosomal dominant polycystic kidney disease lies in a 750-kb CpG-rich region. | 1.50e-05 | 2 | 135 | 2 | 1577479 | |
| Pubmed | Deciphering the role of distinct DNA-PK phosphorylations at collapsed replication forks. | 1.50e-05 | 2 | 135 | 2 | 32674014 | |
| Pubmed | Novel mutations found in two genes of thai patients with isolated methylmalonic acidemia. | 1.50e-05 | 2 | 135 | 2 | 17410422 | |
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 3416632 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 21245310 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 17593081 | ||
| Pubmed | The beneficial effect of blocking Kv1.3 in the psoriasiform SCID mouse model. | 1.50e-05 | 2 | 135 | 2 | 20739949 | |
| Pubmed | Infection of the laboratory mouse with the intracellular pathogen Ehrlichia chaffeensis. | 1.50e-05 | 2 | 135 | 2 | 9673277 | |
| Pubmed | Targeting DNA-PKcs and ATM with miR-101 sensitizes tumors to radiation. | 1.50e-05 | 2 | 135 | 2 | 20617180 | |
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 36293397 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 37833372 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 8418200 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 11924817 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 18172300 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 21643982 | ||
| Pubmed | Evaluation of three lines of immunodeficient mice for the study of spontaneous metastatic tumors. | 1.50e-05 | 2 | 135 | 2 | 10225324 | |
| Pubmed | TACC3 expression is tightly regulated during early differentiation. | 1.50e-05 | 2 | 135 | 2 | 12711550 | |
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 29563550 | ||
| Pubmed | Systematic Analysis of Human Protein Phosphatase Interactions and Dynamics. | PABIR1 INTS7 DUSP7 MCC ITGA9 CCT6A RIF1 CADM1 DUSP16 PRKDC MARCKS | 1.57e-05 | 573 | 135 | 11 | 28330616 |
| Pubmed | Ontogeny of stromal organizer cells during lymph node development. | 3.09e-05 | 16 | 135 | 3 | 20237296 | |
| Pubmed | High-Confidence Interactome for RNF41 Built on Multiple Orthogonal Assays. | 4.35e-05 | 50 | 135 | 4 | 29560723 | |
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 17597648 | ||
| Pubmed | Inhibition of phosphoinositide 3-kinase related kinases by the radiosensitizing agent wortmannin. | 4.48e-05 | 3 | 135 | 2 | 9766667 | |
| Pubmed | Identification and characterization of FUS/TLS as a new target of ATM. | 4.48e-05 | 3 | 135 | 2 | 18620545 | |
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 30224064 | ||
| Pubmed | The TACC domain identifies a family of centrosomal proteins that can interact with microtubules. | 4.48e-05 | 3 | 135 | 2 | 11121038 | |
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 18644470 | ||
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 18451257 | ||
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 23836881 | ||
| Pubmed | DNA Damage Signaling Is Required for Replication of Human Bocavirus 1 DNA in Dividing HEK293 Cells. | 4.48e-05 | 3 | 135 | 2 | 27733644 | |
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 15226440 | ||
| Pubmed | Dynamic change of histone H2AX phosphorylation independent of ATM and DNA-PK in mouse skin in situ. | 4.48e-05 | 3 | 135 | 2 | 17923115 | |
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 29101015 | ||
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 7717446 | ||
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 31601897 | ||
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 25205036 | ||
| Pubmed | ATM phosphorylates histone H2AX in response to DNA double-strand breaks. | 4.48e-05 | 3 | 135 | 2 | 11571274 | |
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 17203969 | ||
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 31164689 | ||
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 18755145 | ||
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 21224054 | ||
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 17957493 | ||
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 31101667 | ||
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 35167491 | ||
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 28789839 | ||
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 23022071 | ||
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 38875319 | ||
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 10677503 | ||
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 26049366 | ||
| Pubmed | The ADAMTS (A Disintegrin and Metalloproteinase with Thrombospondin motifs) family. | 4.48e-05 | 3 | 135 | 2 | 26025392 | |
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 24794298 | ||
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 29242210 | ||
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 27160905 | ||
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 17420264 | ||
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 35067752 | ||
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 23792169 | ||
| Pubmed | [Potentials of DNA-PKcs, Ku80, and ATM in enhancing radiosensitivity of cervical carcinoma cells]. | 4.48e-05 | 3 | 135 | 2 | 17626748 | |
| Pubmed | Ionizing radiation-induced XRCC4 phosphorylation is mediated through ATM in addition to DNA-PK. | 4.48e-05 | 3 | 135 | 2 | 25391321 | |
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 28497574 | ||
| Pubmed | Distinct roles of ATR and DNA-PKcs in triggering DNA damage responses in ATM-deficient cells. | 4.48e-05 | 3 | 135 | 2 | 19444312 | |
| Pubmed | 4.48e-05 | 3 | 135 | 2 | 15389585 | ||
| GeneFamily | Beta-gamma crystallin domain containing | 5.93e-05 | 3 | 81 | 2 | 1360 | |
| GeneFamily | Cation channels sperm associated | 4.10e-04 | 7 | 81 | 2 | 186 | |
| GeneFamily | Schlafen family | 4.10e-04 | 7 | 81 | 2 | 1110 | |
| GeneFamily | MAP kinase phosphatases | 1.06e-03 | 11 | 81 | 2 | 895 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 2.00e-03 | 15 | 81 | 2 | 529 | |
| GeneFamily | ADAM metallopeptidases with thrombospondin type 1 motif | 3.23e-03 | 19 | 81 | 2 | 50 | |
| Coexpression | GSE22886_IGG_IGA_MEMORY_BCELL_VS_BLOOD_PLASMA_CELL_UP | 8.83e-06 | 199 | 134 | 8 | M4444 | |
| Coexpression | GSE7831_1H_VS_4H_INFLUENZA_STIM_PDC_DN | 8.83e-06 | 199 | 134 | 8 | M6964 | |
| Coexpression | GSE5503_MLN_DC_VS_PLN_DC_ACTIVATED_ALLOGENIC_TCELL_DN | 9.16e-06 | 200 | 134 | 8 | M291 | |
| Coexpression | GSE7764_IL15_TREATED_VS_CTRL_NK_CELL_24H_DN | 9.16e-06 | 200 | 134 | 8 | M5724 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL2B | RIPOR2 MCC LAMA5 LRRC4 FASN ADAMTS6 SLFN13 TACC3 CTNND2 LIX1 KIF11 | 1.67e-05 | 439 | 134 | 11 | M39054 |
| Coexpression | BROWNE_HCMV_INFECTION_4HR_DN | 4.80e-05 | 252 | 134 | 8 | M789 | |
| Coexpression | GSE21927_UNTREATED_VS_GMCSF_GCSF_TREATED_BONE_MARROW_DN | 6.08e-05 | 192 | 134 | 7 | M7571 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | USP34 RIPOR2 WWC3 EMB HECTD4 AAK1 BIRC6 WDR26 LYST HOXB2 RIF1 CD6 PVRIG CRYBG1 AKAP13 ARHGAP25 SLFN11 ATM IL7R SORL1 | 7.19e-05 | 1492 | 134 | 20 | M40023 |
| Coexpression | GSE13306_TREG_VS_TCONV_SPLEEN_DN | 7.61e-05 | 199 | 134 | 7 | M3225 | |
| Coexpression | GSE21927_SPLEEN_C57BL6_VS_EL4_TUMOR_BALBC_MONOCYTES_UP | 7.61e-05 | 199 | 134 | 7 | M7596 | |
| Coexpression | GSE37534_UNTREATED_VS_GW1929_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_DN | 7.61e-05 | 199 | 134 | 7 | M8979 | |
| Coexpression | GSE10240_IL22_VS_IL22_AND_IL17_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_DN | 7.86e-05 | 200 | 134 | 7 | M309 | |
| Coexpression | GSE32986_UNSTIM_VS_CURDLAN_HIGHDOSE_STIM_DC_DN | 7.86e-05 | 200 | 134 | 7 | M8618 | |
| Coexpression | GSE21380_NON_TFH_VS_GERMINAL_CENTER_TFH_CD4_TCELL_DN | 7.86e-05 | 200 | 134 | 7 | M7505 | |
| Coexpression | GSE2770_TGFB_AND_IL4_VS_IL12_TREATED_ACT_CD4_TCELL_6H_UP | 7.86e-05 | 200 | 134 | 7 | M6096 | |
| Coexpression | GSE339_CD8POS_VS_CD4CD8DN_DC_IN_CULTURE_DN | 7.86e-05 | 200 | 134 | 7 | M5128 | |
| Coexpression | GSE22886_IGM_MEMORY_BCELL_VS_BM_PLASMA_CELL_UP | 7.86e-05 | 200 | 134 | 7 | M4456 | |
| Coexpression | STK33_SKM_DN | 9.06e-05 | 276 | 134 | 8 | M2856 | |
| Coexpression | FISCHER_DREAM_TARGETS | INTS7 SIVA1 EXOSC5 SAPCD2 BIRC6 RIF1 HINT3 CRYBG1 SLFN11 PRKDC TACC3 GTPBP3 MARCKS KIF11 DNMT3B | 1.34e-04 | 969 | 134 | 15 | M149 |
| CoexpressionAtlas | alpha beta T cells, T.8Nve.PP, TCRb+ CD8+ CD44low CD62L high, Peyer's Patch, avg-1 | RIPOR2 EMB AAK1 BIRC6 ZGPAT RIF1 CD6 ADAMTS6 SLFN13 PRKDC ATM IL7R | 1.52e-06 | 336 | 134 | 12 | GSM538413_500 |
| CoexpressionAtlas | alpha beta T cells, T.8Mem.Sp.OT1.d45.VSVOva, CD8+ CD45.1+, Spleen, avg-3 | RIPOR2 DUSP7 AAK1 LYST ZGPAT CD6 SLFN13 ZFHX2 CRYBG1 IL7R SORL1 | 3.23e-05 | 383 | 134 | 11 | GSM538403_500 |
| CoexpressionAtlas | alpha beta T cells, T.4Nve.PP, TCR+ CD4+ CD44low CD62Lhigh, Peyer's Patch, avg-2 | 4.42e-05 | 327 | 134 | 10 | GSM538380_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_top-relative-expression-ranked_1000 | EMB LAMA5 LRRC4 BIRC6 HOXB2 RIF1 CADM1 WDCP MED12L CRYBG1 CTNND2 TNKS2 PLCH1 SORL1 DNMT3B MGRN1 | 4.63e-05 | 801 | 134 | 16 | gudmap_developingKidney_e15.5_ureter tip_1000_flank cortic collct |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.04e-07 | 186 | 135 | 8 | 9d576dce2c5deefef1adda16c6da7055c8d57f8f | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK-T_Cell-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.04e-07 | 186 | 135 | 8 | bd3bd022b575d9b0ef90d50a5cb874085a827b77 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK-T_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.04e-07 | 186 | 135 | 8 | 924cc357b4c4ce8e9b05773bdab544f0b65474cc | |
| ToppCell | Control-T_cells|Control / group, cell type (main and fine annotations) | 1.08e-07 | 187 | 135 | 8 | f4e8e0eba58da89b56587667555a5d4754e108c7 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.27e-07 | 191 | 135 | 8 | d9a6f61fcda4f5352488f7f55cb9b57aeacc717f | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.33e-07 | 192 | 135 | 8 | 1c0ce299cee9ab5cdea256f3e8c1e5598577a8b6 | |
| ToppCell | Control-Lymphoid-T|Lymphoid / Disease state, Lineage and Cell class | 1.49e-07 | 195 | 135 | 8 | 6687e579582d7a239bee80846de0cf827a6f6a62 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.61e-07 | 197 | 135 | 8 | bf10727fbe90b71d2ac60a11711e5f0701b3799d | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.52e-07 | 86 | 135 | 6 | 79c4326df78f0a5b3ef13b2fb4e5074934536e35 | |
| ToppCell | mild_COVID-19_(asymptomatic)-MAIT|World / disease group, cell group and cell class (v2) | 4.41e-07 | 153 | 135 | 7 | 2b4c69f6db17927d6506a645ac058133e60b0103 | |
| ToppCell | facs-Lung-Endomucin_-18m-Myeloid-Neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.22e-07 | 161 | 135 | 7 | e227f7b711475624cf80e77f235b1783d88d57b4 | |
| ToppCell | facs-Lung-Endomucin_-18m-Myeloid-neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.22e-07 | 161 | 135 | 7 | 8280a029026c272cae9649b27575831b0dd4e242 | |
| ToppCell | facs-SCAT-Fat-24m-Lymphocytic-T_cell|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-06 | 174 | 135 | 7 | 6ca9433d398aa3b48ecdc522dd545119e7c77dd4 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.31e-06 | 180 | 135 | 7 | d9dae9db8e17f6990032ee6cfa8393fae4768ca5 | |
| ToppCell | NS-critical-d_0-4-Lymphoid-Treg|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.47e-06 | 183 | 135 | 7 | f478dfa231fc1b12ead0183cc9d22077cdf43d1f | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.47e-06 | 183 | 135 | 7 | f2ef110bf29b1a8276ef216238363e542db262c1 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.52e-06 | 184 | 135 | 7 | bd786db4dc4edae6d5cfc0b69901983dea19f729 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.52e-06 | 184 | 135 | 7 | 5350b58aa9979631228835d11eb45ddf81d08bff | |
| ToppCell | IPF-Lymphoid-T_Regulatory|IPF / Disease state, Lineage and Cell class | 1.58e-06 | 185 | 135 | 7 | 221cbd09d94cc0947d0e3c1aa14716d17cb2068d | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_T-T_NK-CD4_T_cell|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.58e-06 | 185 | 135 | 7 | 32f43ddc8a899827924834546db33928e353271b | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c05-FOS|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.63e-06 | 186 | 135 | 7 | c793a3d5709ad504c12fc3b2337746d90236d3ca | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.82e-06 | 189 | 135 | 7 | 9ab77c6fcb573854da5922412f53d2168bda6b58 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.82e-06 | 189 | 135 | 7 | 5a9e2ca9a9ee2dc37ab9147a902115a9f1a80169 | |
| ToppCell | Fetal_29-31_weeks-Immune-T_lymphocyte-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.88e-06 | 190 | 135 | 7 | 2a8de1cf27a9ebc3825cf9e7a489ecd064dfc7f9 | |
| ToppCell | IPF-Lymphoid-T|IPF / Disease state, Lineage and Cell class | 1.88e-06 | 190 | 135 | 7 | d57df208aaf7a5554899bb9107c80b443fd0cf93 | |
| ToppCell | Control-T_cells-CD4+_T_cells|Control / group, cell type (main and fine annotations) | 1.88e-06 | 190 | 135 | 7 | 0733be5e54fe15d6d6ea51c154a95258e83f1b92 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.95e-06 | 191 | 135 | 7 | 9bb6a6b88f351217455765ba07a6acf11fda98f4 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.95e-06 | 191 | 135 | 7 | ca5669bd6f4a17471acae3eb229f845cc2e08efa | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 2.02e-06 | 192 | 135 | 7 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | Control-Lymphoid-T|Control / Disease state, Lineage and Cell class | 2.09e-06 | 193 | 135 | 7 | af928046ccd1ca874be1534aef6ca7f27d90bc46 | |
| ToppCell | IPF-Lymphoid-T_Cytotoxic|Lymphoid / Disease state, Lineage and Cell class | 2.09e-06 | 193 | 135 | 7 | 3c8a022dbd4f8d25b14fd137ce64c2713a7dbe41 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.09e-06 | 193 | 135 | 7 | 194b49c152e3e3f599068ec88a7f0af6427b743a | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.16e-06 | 194 | 135 | 7 | 11709704079f24a730476572dc2f01e9d2226e2c | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.16e-06 | 194 | 135 | 7 | 3a1f95639d5f239f001bd67d4213e8938e7f299d | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.16e-06 | 194 | 135 | 7 | a44be2f021cfdd0fcdc698c3f04d66db7a1aa6c2 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.31e-06 | 196 | 135 | 7 | 7e5addaa844e66f8160e05858c341866a80aed23 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-lymphocytic-T_lymphocytic-T_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.31e-06 | 196 | 135 | 7 | 4a880a5d2c7047c050c7d6dd62186f35dc5c01f7 | |
| ToppCell | LPS_anti-TNF-Hematopoietic_Lymphocytic-Lymphocytic_NK/T-T-cells|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.56e-06 | 199 | 135 | 7 | 618dc6425bb7b84d3b2de7cf8ecb41549a255718 | |
| ToppCell | medial-Hematologic-CD4+_Naive_T-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.56e-06 | 199 | 135 | 7 | 6a896a447388fd525cff207e17a5371c0f6b38cb | |
| ToppCell | medial-2-Hematologic-CD4+_Naive_T|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.56e-06 | 199 | 135 | 7 | 231a539899e2b76215da3e96a6755799f722e278 | |
| ToppCell | medial-Hematologic-CD4+_Naive_T|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.56e-06 | 199 | 135 | 7 | a54c35a646ae23bdd35c278ffb027408cf8dd553 | |
| ToppCell | LPS-antiTNF-Myeloid-Monocytes,_Macrophages-T-cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.73e-06 | 136 | 135 | 6 | 186be8e1595608004b8216892cb9c7a7f31fbb4d | |
| ToppCell | mild_COVID-19_(asymptomatic)-MAIT|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 7.34e-06 | 153 | 135 | 6 | 26852f3d8f80e102e24bcb90e24aac26fdc9a32c | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Myeloid-neutrophil|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-05 | 165 | 135 | 6 | 4fe7c3c9370a556cf4e308a2e723b4b907a6cc25 | |
| ToppCell | severe-CD4+_T_naive|severe / disease stage, cell group and cell class | 1.21e-05 | 167 | 135 | 6 | 02a8215fca59c357c1cdaa5738849eacf98c0bcc | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-Lgr5+_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-05 | 168 | 135 | 6 | d69452e2cfeb74023b5cf3d09064d7dcad0008ec | |
| ToppCell | facs-SCAT-Fat-18m-Lymphocytic-T_cell|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-05 | 169 | 135 | 6 | 700a3a36c379872585204caa6a6cc269b036ae22 | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD8_T-CD8_T_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.34e-05 | 170 | 135 | 6 | a0d6466e00bd3dc07f644ba3f87d5b421fd479d5 | |
| ToppCell | 3'_v3-lymph-node_spleen|World / Manually curated celltypes from each tissue | 1.38e-05 | 171 | 135 | 6 | 7aae88da5b37c20f10118325a048f08906be994c | |
| ToppCell | facs-Lung-nan-3m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-05 | 171 | 135 | 6 | a31c23406cf6d6a17358a8fb41d392a7fb0306e0 | |
| ToppCell | facs-Lung-nan-3m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-05 | 171 | 135 | 6 | 43d8fd9b9546e84a652564fe96b514b34b06262b | |
| ToppCell | P15-Mesenchymal-developing_mesenchymal_cell-mesenchymal_proliferating_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.43e-05 | 172 | 135 | 6 | 7c238a7375341d4647ba7274d93fddfb6fae7ce4 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.58e-05 | 175 | 135 | 6 | e5467dacf81f1f913b1719931cf1a7331434a7e7 | |
| ToppCell | wk_20-22-Hematologic-Myeloid-Promyelocyte-like|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.63e-05 | 176 | 135 | 6 | ee33d7077a92c1fd371081e7c990c7266e711957 | |
| ToppCell | 3'-Adult-SmallIntestine-Hematopoietic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.74e-05 | 178 | 135 | 6 | da1695a936dbe3ca9ee3fb28ceb60511c47b35f8 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_B_(ET)-Glut_ET_L5_FEZF2-Exc_L5_FEZF2_MORN2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.74e-05 | 178 | 135 | 6 | b0fc56f583cb3f2977fe2306994c0d478c9a6b1b | |
| ToppCell | 3'-Adult-SmallIntestine-Hematopoietic-B_cells|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.74e-05 | 178 | 135 | 6 | 580fc1d45b82010c665a313b2e7a21e0116819ef | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.85e-05 | 180 | 135 | 6 | f3d35b2ea78afef37a84232adf5e6e26712b618d | |
| ToppCell | COVID-19-kidney-NK|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.91e-05 | 181 | 135 | 6 | 8906ee8a7a1616dfe8c3b5c73988416641213629 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Hematopoietic|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.91e-05 | 181 | 135 | 6 | 9dc0563453e24c9d1d975e2e0e1e272487e19908 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Hematopoietic-Megakaryocytic|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.91e-05 | 181 | 135 | 6 | 14c2dd946e89ba578711c2d25935b6b3d319b701 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Hematopoietic-Megakaryocytic-Megakaryocyte|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.91e-05 | 181 | 135 | 6 | c5843b89f3d362e236ff76c3279518a2fdfc1f75 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 1.91e-05 | 181 | 135 | 6 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.91e-05 | 181 | 135 | 6 | 5f2d3a08577c440c944778d07aa993c6e7873f3d | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Hematopoietic-Megakaryocytic-Megakaryocyte-Mega|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.91e-05 | 181 | 135 | 6 | fcefb5902416c004631f4f8dd5c8f99fe3bd90bc | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.91e-05 | 181 | 135 | 6 | c7c5f7d4c397b4613c772413a0a679377efffff3 | |
| ToppCell | RA-17._Lymphocyte|RA / Chamber and Cluster_Paper | 1.97e-05 | 182 | 135 | 6 | 257a7847917b6ea1d60608183d90300bfd028758 | |
| ToppCell | 5'-Adult-LymphNode-Endothelial-blood_vessel_EC-Mature_venous_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.03e-05 | 183 | 135 | 6 | a644258ba90acc62d571623e429d72ffc4b69203 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.03e-05 | 183 | 135 | 6 | 5e361be3ae3fe05098968e58427630127bd12675 | |
| ToppCell | RA-17._Lymphocyte|World / Chamber and Cluster_Paper | 2.03e-05 | 183 | 135 | 6 | 6397f684a50346fc42cccb5afbe10350f4b2d9b0 | |
| ToppCell | IPF-Lymphoid-T_Regulatory|World / Disease state, Lineage and Cell class | 2.16e-05 | 185 | 135 | 6 | 77fbecdab10bacc005b1c7e22ca414cfecef13c1 | |
| ToppCell | Control-T_cells-CD8+_T_cells|Control / group, cell type (main and fine annotations) | 2.16e-05 | 185 | 135 | 6 | 02ab64c0166c0646d1d4c6ed110ef0b75a1096d0 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.29e-05 | 187 | 135 | 6 | 4ae7465174e0295d2c3b614b321a3b2f514dd22a | |
| ToppCell | systemic_lupus_erythematosus-flare-Hematopoietic-Progen|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.29e-05 | 187 | 135 | 6 | 16fffe894a2c7d5186556ad000e0be229511fbdb | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.1.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.29e-05 | 187 | 135 | 6 | 7c44cec1c26ca5907a495f2d7e633410e2e9728f | |
| ToppCell | (1)_T_CD4_naive|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 2.36e-05 | 188 | 135 | 6 | b8f67ac2faadd5b848955e43ab5d6cf5e49b3681 | |
| ToppCell | IPF-Epithelial-ATII|Epithelial / Disease state, Lineage and Cell class | 2.36e-05 | 188 | 135 | 6 | 5f5fad2773e421760e67dbace23fd1f847a2e1e0 | |
| ToppCell | human_hepatoblastoma-NK.T_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.36e-05 | 188 | 135 | 6 | 71b7599e7e1d63cc0c8518c0501533755951d58f | |
| ToppCell | Children_(3_yrs)-Immune-T_lymphocyte-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.43e-05 | 189 | 135 | 6 | df30478b288084a1bd48f660409dcc784040897c | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D231|Adult / Lineage, Cell type, age group and donor | 2.43e-05 | 189 | 135 | 6 | dab54a52358f66a8a9460cd6089a06c5fa7e7a5d | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.43e-05 | 189 | 135 | 6 | fb2253b8463d08b3d28e952a31a23dea2c2d986b | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.43e-05 | 189 | 135 | 6 | c8b8f860aaf6c73863cd79941db6b469c830ef06 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.51e-05 | 190 | 135 | 6 | 8aea807a2bcf0b653b4de6202b6ecb0f0683cc2e | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.51e-05 | 190 | 135 | 6 | 625c08a0e5227efc46daa512fd579c3938ff76c7 | |
| ToppCell | IPF-Lymphoid-T_Cytotoxic|IPF / Disease state, Lineage and Cell class | 2.51e-05 | 190 | 135 | 6 | e5d0186bfb416a3eda76ac12b9379650afb6f409 | |
| ToppCell | NS-critical-d_0-4-Lymphoid|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.51e-05 | 190 | 135 | 6 | 84f9f5ac29ff0f929a589b76efa61d4c570e76b0 | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.51e-05 | 190 | 135 | 6 | 0a351609a72fd638c84b2435782e312ee6a33aac | |
| ToppCell | 5'-Adult-LymphNode-Endothelial-blood_vessel_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.51e-05 | 190 | 135 | 6 | 141266bf411ea675fbf889b20c1b08673c45ff95 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.58e-05 | 191 | 135 | 6 | d9506b88d806aadd4c2b9bf86fe994c47799e7f6 | |
| ToppCell | CV-Moderate-0|Moderate / Virus stimulation, Condition and Cluster | 2.58e-05 | 191 | 135 | 6 | 6776bcc4c1915f0c1062002ff7746f20ceb725f4 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK-T_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.58e-05 | 191 | 135 | 6 | b42c54308abe1241cc38ddce96b9d38d07983891 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.58e-05 | 191 | 135 | 6 | 39220f4a345e328f7fa4fd462a0abeea821b3e02 | |
| ToppCell | COVID-19-lung-CD4+_Treg|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.58e-05 | 191 | 135 | 6 | 5a4ad5ae5c2dbfb225158cb598ef649c26a48350 | |
| ToppCell | COVID-19-kidney-Proliferating_T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.58e-05 | 191 | 135 | 6 | bae388e0e9447d576e68465d73d8313ef6925ffa | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK-T_Cell-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.58e-05 | 191 | 135 | 6 | 9aabbc65430e2233b8f2d3fff9face7807b88b48 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.66e-05 | 192 | 135 | 6 | 3abee376c37c3646da33ac381aa63d50a01607a6 | |
| ToppCell | COPD-Lymphoid-T|World / Disease state, Lineage and Cell class | 2.66e-05 | 192 | 135 | 6 | eb4909574fb5fc91399463523e2737095773200a | |
| ToppCell | Fetal_29-31_weeks-Immune-T_lymphocyte|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.66e-05 | 192 | 135 | 6 | 69a2b04f03a1b82d067018379f7b8a116e954040 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_proliferating-epi_proliferating3_(5)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.66e-05 | 192 | 135 | 6 | d3634574b2e8d2ded6446969361b70761b331aea | |
| ToppCell | COVID-19_Severe-CD4+_Tcm|World / disease group, cell group and cell class | 2.66e-05 | 192 | 135 | 6 | 3352f13a6e706991dcf3ec173587bb6aba36a385 | |
| Drug | Lumicolchicine gamma [6901-14-0]; Down 200; 10uM; MCF7; HT_HG-U133A | 2.39e-06 | 195 | 134 | 9 | 3254_DN | |
| Disease | mean corpuscular hemoglobin concentration | ANK1 HECTD4 GRB14 ENTHD1 GMPR2 ABCA7 ZGPAT RIF1 KRBA1 AKAP13 LTBR PRKDC MMAB DNASE1L2 ABCC10 | 9.23e-05 | 1105 | 128 | 15 | EFO_0004528 |
| Disease | methylmalonic acidemia (implicated_via_orthology) | 1.11e-04 | 4 | 128 | 2 | DOID:14749 (implicated_via_orthology) | |
| Disease | aspartate aminotransferase measurement | WWC3 HECTD4 THSD7B ITGA9 SAPCD2 BIRC6 ZGPAT CADM1 ADAMTS6 PCDHGB4 AKAP13 LTBR MMUT | 1.59e-04 | 904 | 128 | 13 | EFO_0004736 |
| Disease | fibroblast growth factor receptor 3 measurement | 1.85e-04 | 5 | 128 | 2 | EFO_0020390 | |
| Disease | Methylmalonic acidemia | 1.85e-04 | 5 | 128 | 2 | cv:C0268583 | |
| Disease | diabetes mellitus | 2.22e-04 | 68 | 128 | 4 | EFO_0000400 | |
| Disease | monocyte percentage of leukocytes | CALCOCO1 NBPF4 WDR26 FCHO1 AKAP13 ARHGAP25 LTBR PRKDC MMAB MARCKS IL7R | 3.53e-04 | 731 | 128 | 11 | EFO_0007989 |
| Disease | monocyte count | MARS2 ANK1 GCNT1 LYST ZNF608 DUSP16 PKD1 MED12L AKAP13 ARHGAP25 LTBR PRKDC ATM MARCKS SORL1 | 6.15e-04 | 1320 | 128 | 15 | EFO_0005091 |
| Disease | lymphocyte percentage of leukocytes | RIPOR2 ANK1 ABCA7 ZGPAT FASN ARHGAP25 LTBR PRKDC IL7R DNMT3B | 6.62e-04 | 665 | 128 | 10 | EFO_0007993 |
| Disease | Malignant neoplasm of breast | NPBWR1 ANK1 TACC2 ITGA9 RIF1 FASN CADM1 PER2 WDCP ATM SPOCD1 SORL1 DNMT3B | 8.13e-04 | 1074 | 128 | 13 | C0006142 |
| Disease | alcohol consumption measurement | TSHZ2 CALCOCO1 ENTHD1 CRTAC1 THSD7B BIRC6 ZNF608 SLC2A13 CTNND2 PLCH1 MMAB PLXNA2 SORL1 DNMT3B | 1.02e-03 | 1242 | 128 | 14 | EFO_0007878 |
| Disease | Cardiomyopathy, Familial Idiopathic | 1.35e-03 | 50 | 128 | 3 | C1449563 | |
| Disease | neutrophil percentage of leukocytes | 1.40e-03 | 610 | 128 | 9 | EFO_0007990 | |
| Disease | reticulocyte measurement | USP34 ANK1 HECTD4 HEMGN GRB14 BIRC6 PCDHGB4 ZFAND6 AKAP13 ARHGAP25 SPOCD1 MMAB | 2.14e-03 | 1053 | 128 | 12 | EFO_0010700 |
| Disease | Malignant Neoplasms | 2.38e-03 | 128 | 128 | 4 | C0006826 | |
| Disease | myeloid white cell count | USP34 HECTD4 MCC ABCA7 FCHO1 PKD1 MED12L LTBR TNKS2 IL7R SORL1 | 2.61e-03 | 937 | 128 | 11 | EFO_0007988 |
| Disease | Disorder of organic acid metabolism | 2.73e-03 | 18 | 128 | 2 | cv:C1263739 | |
| Disease | amino acid measurement | 2.86e-03 | 678 | 128 | 9 | EFO_0005134 | |
| Disease | unipolar depression, response to bupropion, mood disorder | 3.04e-03 | 19 | 128 | 2 | EFO_0003761, EFO_0004247, EFO_0006326 | |
| Disease | Crohn's disease | 3.19e-03 | 441 | 128 | 7 | EFO_0000384 | |
| Disease | Benign Neoplasm | 3.25e-03 | 68 | 128 | 3 | C0086692 | |
| Disease | Neoplasms | 3.25e-03 | 68 | 128 | 3 | C0027651 | |
| Disease | insomnia measurement | 3.27e-03 | 443 | 128 | 7 | EFO_0007876 | |
| Disease | sucrose liking measurement | 3.37e-03 | 20 | 128 | 2 | EFO_0010157 | |
| Disease | unipolar depression, bipolar disorder, schizophrenia | 3.37e-03 | 20 | 128 | 2 | EFO_0003761, MONDO_0004985, MONDO_0005090 | |
| Disease | Severe Combined Immunodeficiency | 3.37e-03 | 20 | 128 | 2 | C0085110 | |
| Disease | Intellectual Disability | 3.44e-03 | 447 | 128 | 7 | C3714756 | |
| Disease | ulcerative colitis | 3.49e-03 | 335 | 128 | 6 | EFO_0000729 | |
| Disease | inflammatory bowel disease | 3.52e-03 | 449 | 128 | 7 | EFO_0003767 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VALNSFDDLSPDCLG | 331 | P40227 | |
| IELEPGLSSSAACNG | 21 | Q4G0N7 | |
| SPCAEIAGAAVSEIS | 431 | Q9Y5Z0 | |
| LRNCAASGSDPTDLN | 3401 | Q9NR09 | |
| LAGGPLSNLSENTCD | 361 | Q7RTX7 | |
| PFGLEEVNESSCLSS | 611 | Q9H7T0 | |
| FEDSNACGALSSPIL | 2546 | Q68DQ2 | |
| ILVNGACSDQSSDSP | 21 | Q9UBC3 | |
| GEDSLLDCSLLSNPT | 861 | Q2M2I8 | |
| SLQDELLSPASLGCA | 1516 | P16157 | |
| LDASDLASPSSCNFL | 336 | Q969Y2 | |
| LLPDGSDGSDALNCS | 1046 | Q12802 | |
| AAELARDLTCPTGAS | 66 | A5YM72 | |
| EAAESPCALGAALSA | 71 | Q9NYJ7 | |
| ENALGVCSDTAAPLA | 86 | P16066 | |
| ECSNPDTLEGAAGAL | 856 | Q9UQB3 | |
| AATEACQLPTSSGDA | 61 | Q8IWE4 | |
| EASSVALSNCDGLAG | 166 | O95450 | |
| APAVIDGTQCNADSL | 666 | Q9UKP5 | |
| SSLSPACSELIGALD | 261 | Q8IZY2 | |
| PSGDLQREESLAACS | 686 | Q6UXK2 | |
| LACSALDVASPTEAA | 466 | Q96M43 | |
| ESLLVLCSQDDSPGA | 391 | Q9NVH2 | |
| ALAAQGLPVSCTAES | 231 | P10746 | |
| DSSGALFPLCNSSEL | 781 | Q9UN71 | |
| AANATLAGAPALLCS | 116 | P30203 | |
| VCNLSGADAVPTLSE | 271 | Q8IYW4 | |
| CSPEAAAAQLRATAG | 371 | O14526 | |
| ACALNDDLSILPAGD | 701 | Q5T3U5 | |
| RPSCSQDLEAGLSEA | 416 | O60320 | |
| DLNPESFAISLTCGD | 61 | Q3ZCW2 | |
| AASASSSPLEALEAC | 376 | A5PL33 | |
| VALPSLLAAACGDAD | 1106 | Q86YW9 | |
| SLVSSQDCQLESDGP | 461 | Q6ZRS4 | |
| LSQEPSVDAGVDCSS | 991 | P52732 | |
| VNRSAGLAPDCEASA | 6 | Q9NQE9 | |
| DGLSQASCPLAAIDH | 421 | O60291 | |
| VEDAASGPESLDCLA | 691 | O15055 | |
| LNEDLCSASGSAASE | 1061 | O15055 | |
| VVSDAPDLSAGIACA | 581 | O75051 | |
| PLNLSLAGEATTCAA | 6 | P34995 | |
| DPAAASISDGDCDAR | 21 | Q8IW50 | |
| AGTPCLSLDLSDSNL | 1031 | Q9ULH7 | |
| AACAPLDSGASENSR | 571 | Q86XN8 | |
| LCAAIAAAASAGPQN | 31 | Q9HBW1 | |
| AGNVSACDAPILSSS | 371 | P16871 | |
| QNPDCLEHLAASSGT | 91 | Q9P2T1 | |
| ACALDSDGTLVLDPT | 156 | Q9NQT4 | |
| ARIAASATCGEEAPA | 56 | O15230 | |
| PSAAGLEALCRQDNS | 1056 | O15230 | |
| GDLLCSLAASDPDSG | 471 | Q9Y5F7 | |
| SSDVAQLSDPGVCVS | 226 | Q96E09 | |
| QLSDPGVCVSSDTLD | 231 | Q96E09 | |
| TSDAIADACQALVGP | 2956 | Q9Y4D8 | |
| PAADACSDLASQSDG | 196 | Q9UPP2 | |
| TSEDTADLAGCSLQA | 246 | Q9BXL5 | |
| SSPSDDQLSLTALCG | 266 | Q8N485 | |
| PSATNLCFDVADAGA | 76 | Q96IR7 | |
| STICSINALDFDAGP | 2786 | Q6V1P9 | |
| AADSCLQLSGGLSPS | 311 | P14652 | |
| TACDLAPRAGTTDAA | 491 | P10696 | |
| SSLCAVDLNGDGLSD | 306 | Q13797 | |
| LPSGSQCAAAAAAAA | 6 | Q9BY67 | |
| QSTDLCDFSGDLDPA | 1361 | Q13315 | |
| ECADAASPALSLAEL | 696 | P23508 | |
| SPLAAARTESGCDAE | 186 | A4D1S0 | |
| LIPDSADTTVGNSDC | 231 | Q92874 | |
| EECELASPGTAASEN | 396 | Q8N3K9 | |
| CADSATSEAAGQRPV | 341 | Q9BY84 | |
| GLSSPCDNHASSEQL | 386 | Q16829 | |
| CTAALHIPANEGDAS | 91 | Q5T1N1 | |
| GNLCDAELSSSLSSP | 656 | Q99698 | |
| EAGASAAACEAPSAA | 271 | P29966 | |
| AARDSPLAAQVCGAA | 16 | Q14449 | |
| GPILSSSASDIFCDN | 246 | Q9NQ79 | |
| QCLLAAARPSSADGS | 21 | Q6PCB8 | |
| VQTDAGCLSEPVASA | 381 | Q9Y4K1 | |
| ASGLPSCDAAVNLAG | 46 | Q9NRG7 | |
| GDLCEASLTNSVEPA | 536 | A8MQT2 | |
| LELAGENPSSDINCT | 46 | Q02742 | |
| NCAVAALGDPASALS | 1316 | P49327 | |
| DTSIASRGAPESCND | 411 | Q92622 | |
| CLSPESSAEALEAAV | 516 | Q68D06 | |
| AAVGLSCPAALTDSE | 526 | Q9P1Z2 | |
| DCSDLGLSELPSNLS | 51 | O75473 | |
| LQDVGSALATPCSSA | 121 | Q96EY8 | |
| VACLPDNSSGTVAAV | 181 | P98161 | |
| GPDPALSCSNASTLA | 16 | P48145 | |
| SSAAQPGCSVLDEAF | 51 | P06865 | |
| DAASAAGECSLLAAA | 31 | Q96QE2 | |
| DGSDEEACPLLANVT | 1446 | Q92673 | |
| PGALADLDCSSSSQS | 146 | Q9Y6A5 | |
| LEGSNDALLCGNSSD | 351 | P35499 | |
| VDPSILAACLESAGN | 271 | Q17RQ9 | |
| LACSALDVASPTEAA | 466 | Q5VWK0 | |
| EEPSQCLASGTAISE | 2121 | Q5UIP0 | |
| CGLEASQVPAEEALS | 71 | Q1AE95 | |
| CTETGANLFDLSPEN | 581 | A6NCM1 | |
| SETSGSCALNPEEVL | 1166 | Q9ULL8 | |
| LSEDFECQLSLSSGP | 361 | Q7Z7L1 | |
| CLSPESSAEALEAAV | 516 | Q7Z7L1 | |
| LSFSDLPNGDCALTS | 431 | Q9Y4F9 | |
| LASSCGEAVASGLQP | 51 | O94993 | |
| SLDPSDAFNGVDCNS | 141 | O75153 | |
| LLPEGLTSDAQCDDS | 316 | Q9BTX7 | |
| GIISFASSCAQEDAP | 241 | Q2L4Q9 | |
| SASNEPLAFASCGTE | 101 | P82912 | |
| ASPVDDEQLSVCLSG | 491 | Q96HI0 | |
| SSVSSDAPGNVLCAL | 366 | Q9ULJ3 | |
| ASPESEACSLSAGDL | 2016 | Q9C0A1 | |
| CGLEASQVPAEEALS | 71 | Q8IXX5 | |
| ALEPSSSADAGAVAC | 181 | Q86UD0 | |
| AAVASPTGNCDLERF | 551 | Q6P1M0 | |
| GSSEEALGDLACSSL | 11 | Q96PX9 | |
| APQALAFCSNSGDLV | 731 | A6NE52 | |
| LEQGLAAPADTCASS | 376 | Q6ZMY3 | |
| SPGEEASALSSQACD | 511 | P42331 | |
| CSPASLSQASADLEA | 186 | Q14258 | |
| CTDGSVPEAQSALDS | 66 | Q6FIF0 | |
| LNTPSSLAVCADGEL | 1536 | Q6N022 | |
| LSTAETQACASGDLP | 1711 | O95359 | |
| PSCSQQDLSRLGAED | 776 | O15040 | |
| QAAATAGLAPTELCD | 101 | Q96GW9 | |
| EPTSALSNGCALANH | 671 | Q9NRE2 | |
| AACASAAAEAVEPAA | 11 | Q9H2K2 | |
| ADPTLCFNSGESSLV | 1346 | Q4KWH8 | |
| LDPAAVSAGCLASLQ | 2871 | P78527 | |
| LVEAAPGTAQSDTTC | 196 | P36941 | |
| AALDSCSAADGSLAA | 681 | Q9ULD9 | |
| ADLRSCDGQALPSQD | 3481 | Q70CQ2 | |
| ELACLSAQNGESSPS | 31 | Q9H7D7 | |
| GPCSEDTLVTALNAT | 671 | Q9C0I4 | |
| SPLSSICDGSIALDA | 501 | Q9H6R7 | |
| LILEGSGASSPCANT | 116 | Q6DKI7 | |
| CDQDIALILPSSSEG | 1291 | Q69YN4 | |
| ASEADPSGVASIACS | 101 | O15304 | |
| QDPDLSSLQAGSACL | 211 | Q8N5A5 | |
| AVDSAQSSALCPSLA | 296 | Q8N5A5 | |
| QSSALCPSLAVVGSD | 301 | Q8N5A5 | |
| SRDSPLAQLADSCEG | 476 | Q9ULE0 | |
| CLELLGSSDLPASAS | 86 | O14628 | |
| ALTECAASGDGNILA | 536 | P22033 |